APA (7th ed.) Citation

Bracke, M. M. G., Polet, S. S., Plantinga, M., & de Koning, T. J. (2025). Mitigating the impact of study-start delays in clinical trials for rare disorders: Insights and lessons from a PKAN trial. Orphanet Journal of Rare Diseases, 20(1), 1. https://doi.org/10.1186/s13023-025-04035-1

Chicago Style (17th ed.) Citation

Bracke, Marleen M. G., Sjoukje S. Polet, Mirjam Plantinga, and Tom J. de Koning. "Mitigating the Impact of Study-start Delays in Clinical Trials for Rare Disorders: Insights and Lessons from a PKAN Trial." Orphanet Journal of Rare Diseases 20, no. 1 (2025): 1. https://doi.org/10.1186/s13023-025-04035-1.

MLA (9th ed.) Citation

Bracke, Marleen M. G., et al. "Mitigating the Impact of Study-start Delays in Clinical Trials for Rare Disorders: Insights and Lessons from a PKAN Trial." Orphanet Journal of Rare Diseases, vol. 20, no. 1, 2025, p. 1, https://doi.org/10.1186/s13023-025-04035-1.